	Influencing Factors of Unmet Care Needs Among Taiwanese Non-Muscle Invasive Bladder Cancer during Acute Stage of Survivorship: A Preliminary Study. Asian Nurs Res (Korean Soc Nurs Sci) Chen YR, Jou YC, Lin YC, Huang HP, Beaton RD, Jane SW. PMID: 41397621 [PubMed - as supplied by publisher]
	Sequential Use of Targeted Radioligand Therapies in Metastatic Castration-Resistant Prostate Cancer: A Case Report and Systematic Review. Crit Rev Oncol Hematol Bölek H, Araz M, Soydal C, Yekedüz E, Küçük NÖ, Ürün Y. PMID: 41397584 [PubMed - as supplied by publisher]
	Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitors. Can Urol Assoc J Hanna L, O'Dwyer R, Hamilou Z, Noonan K, Doucette S, Sridhar SS. PMID: 41397370 [PubMed]
	Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer. J Clin Oncol Gore JL, Wolff EM, Nash MG, Comstock BA, Gilbert SM, Chang SS, Chisolm S, MacLean DB, Wright JL, Kates MR, Pohar KS, Guzzo TJ, Bivalacqua TJ, Nepple KG, Montgomery JS, Scarpato KR, Woldu SL, Master VA, Chen DYT, Mossanen M, Daneshmand S, O'Neil BB, Tyson MD, Westerman ME, Kamat AM, Mansour AM, Chamie K, Riggs SB, Kukreja JB, Modi PK, Garg T, Peyton CC, Nix JW, Dickstein R, Gadzinski AJ, Sankin A, Shore ND, Lane BR, Bassett JC, Patel S, Morris DS, Macleod LC, Lee EK, Ritch CR, Follmer KM, Lee JR, Kim SM, Kessler LG, Smith AB, CISTO Collaborative group. PMID: 41397208 [PubMed - as supplied by publisher]
	Patient-reported long-term sexual morbidity in prostate cancer survivors treated with external beam radiation therapy alone or combined with high-dose-rate brachytherapy. Scand J Urol Wedde TB, Hagen MS, M Vatne K, Nilsen LB, Hellebust TP, Lilleby W. PMID: 41396780 [PubMed - indexed for MEDLINE]
	A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives. World J Urol Bertrand C, Ouzaid I, Guerrero-Ramos F, Marcq G, Sfakianos JP, Xylinas E, Gabriel PE. PMID: 41396440 [PubMed - indexed for MEDLINE]
	Comparative analysis of AI-generated and deformed image registration contours on daily CBCT in prostate cancer radiation therapy: accuracy and dosimetric implications using commercial tools. Phys Eng Sci Med Ashburner M, Huang R, Chin J, Aly M. PMID: 41396387 [PubMed - as supplied by publisher]
	Diagnostic utility of serum prostate-specific antigen and circulating inflammatory markers for differentiating prostate cancer from benign prostatic hyperplasia. Am J Cancer Res Luo D, Xie H. PMID: 41395283 [PubMed]
	Corrigendum to "Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis" [Heliyon Volume 10, Issue 12, June 30, 2024, Article e32875]. Heliyon Razavinia A, Razavinia A, Jamshidi Khalife Lou R, Ghavami M, Shahri F, Tafazoli A, Khalesi B, Hashemi ZS, Khalili S. PMID: 41395027 [PubMed]
	Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis. Front Immunol Chen K, Zhuo L, Liu Z, Ge L, Yu L, Zhang S. PMID: 41394875 [PubMed - indexed for MEDLINE]
	Utilization of artificial intelligence in prostate cancer detection: a comprehensive review of innovations in screening and diagnosis. Front Immunol Rajih E, Bakhsh A, Borhan WM, Alqahtani SAM. PMID: 41394863 [PubMed - indexed for MEDLINE]
	Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a retrospective study. Front Immunol Mao KF, Sun J, Sun C, Sun BB, Wu ZG, Cai J, Zhou CF. PMID: 41394847 [PubMed - indexed for MEDLINE]
	Neoadjuvant chemoradiotherapy plus programmed cell death protein-1 blockade versus chemoradiotherapy alone for muscle-invasive bladder cancer: a real-world comparative study. Front Immunol Zhang F, Wang J, Yu Y, Zhang C, Ouyang J, Zhang Z. PMID: 41394840 [PubMed - indexed for MEDLINE]
	Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study. Prostate Int Kitano H, Hashimoto K, Hasegawa Y, Fujita A, Shinmei S, Kirishima F, Shirane S, Asami A, Naito M, Kohada Y, Kobatake K, Sekino Y, Kato M, Kadonishi Y, Mochizuki H, Kajiwara M, Hinata N. PMID: 41393332 [PubMed]
	Sex disparities in bladder cancer diagnosis: evidence from the UK Biobank. World J Urol Shweiki D. PMID: 41392204 [PubMed - in process]
	Electrochemical MicroRNA biosensors for kidney Cancer: From biomarker discovery to point-of-care diagnostics. Clin Chim Acta Zarei S, Hosseiniara SM, Zijoud SSH, Hosseiniara R. PMID: 41391580 [PubMed - as supplied by publisher]
	Serum per- and polyfluoroalkyl substances in relation to circulating thyroxine levels and thyroid cancer risk: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial cohort. Environ Int Jung EM, Rhee J, Keil AP, Kitahara CM, Moore SC, Koponen J, Rantakokko P, Purdue MP. PMID: 41391234 [PubMed - as supplied by publisher]
	Primary tumor and metastasis-directed treatment for oligometastatic prostate cancer: An umbrella review of meta-analyses. Cancer Treat Rev Petrelli F, Trevisan F, Bruschieri L, Riboldi V, Vavassori I, Seghezzi S, Esposito A, Dottorini L, Stefani A. PMID: 41391209 [PubMed - as supplied by publisher]
	HPV and urological cancers: Investigating renal and prostate cancer associations. Urol Oncol Ayman M, Irfan A, Farouk K, Sultana N, Usman M, Zulfiqar S, Asghar S, Javed A, Justin S. PMID: 41391000 [PubMed - indexed for MEDLINE]
	Palliative and hospice care in prostate cancer: A scoping review. Urol Oncol Glaza A, Kennedy A, Jabeer M, Ramanathan S, Obeng A, Zwaans B, Hafron J. PMID: 41390998 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 174582

Page 1 of 8730



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy